FDA Approves Auro’s Anti-allergic Syrup

by Rajshri on  December 17, 2009 at 10:00 PM Corporate News   - G J E 4
 FDA Approves Auro’s Anti-allergic Syrup
One of India's leading pharmaceutical companies, Aurobindo Pharma has bagged approval from the US Food and Drug Administration for its anti-allergic Cetirizine Hydrochloride Syrup.

Similar to McNeil Consumer Healthcare's Zyrtec syrup, the Cetirizine Hydrochloride Syrup provides relief from symptoms of seasonal allergic rhinitis such as repetitive sneezing, nasal congestion and itchy eyes.

Announcing the approval, the company released a statement in the Bombay Stock Exchange stating "The company has received final approval for Cetirizine Hydrochloride syrup from the US Food and Drug Administration (FDA)." It added that the approval was for the strength of 1mg/ml.

The company revealed that it has around 110 new drug applications with the FDA of which 82 have been awarded final approvals.

Source: Medindia

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like